C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Acquires Shares of 2,305 The Clorox Company (NYSE:CLX)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in The Clorox Company (NYSE:CLXFree Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,305 shares of the company’s stock, valued at approximately $374,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Brooklyn Investment Group boosted its stake in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new position in Clorox in the 3rd quarter worth about $27,000. Continuum Advisory LLC boosted its position in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares in the last quarter. Carolina Wealth Advisors LLC acquired a new stake in Clorox in the third quarter valued at approximately $48,000. Finally, Friedenthal Financial purchased a new stake in shares of Clorox in the third quarter valued at approximately $49,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CLX has been the topic of several research analyst reports. DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. Barclays upped their price target on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. Finally, Wells Fargo & Company lifted their price objective on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Clorox currently has a consensus rating of “Hold” and an average price target of $158.21.

View Our Latest Analysis on CLX

Clorox Trading Up 1.4 %

Shares of NYSE:CLX opened at $150.77 on Friday. The company has a market cap of $18.66 billion, a PE ratio of 41.19, a P/E/G ratio of 2.52 and a beta of 0.42. The company’s 50 day moving average is $159.93 and its two-hundred day moving average is $159.19. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the business posted $2.16 earnings per share. Equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.24%. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.